FDA Holds Hearing on CBD as CA Moves Forward on Hemp
About 100 people testified at a public hearing held on May 31 by the FDA “in order to inform the regulatory path forward” on CBD. Manufacturers, researchers, doctors, laboratory representatives, lawyers and advocates (pro and con) were among those who spoke. Speakers expressed concern over the lack of uniformity and purity of available CBD preparations, …